GALT - Galectin Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts2223
Avg. Estimate-0.12-0.12-0.46-0.78
Low Estimate-0.12-0.12-0.46-1.06
High Estimate-0.11-0.11-0.45-0.53
Year Ago EPS-0.14-0.13-0.49-0.46
Revenue EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts1123
Avg. EstimateN/AN/AN/A5M
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/A15M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History6/29/20179/29/201712/30/20173/30/2018
EPS Est.-0.15-0.14-0.11-0.13
EPS Actual-0.14-0.13-0.07-0.12
Difference0.010.010.040.01
Surprise %6.70%7.10%36.40%7.70%
EPS TrendCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.12-0.12-0.46-0.78
7 Days Ago-0.12-0.12-0.46-0.78
30 Days Ago-0.13-0.1-0.48-0.69
60 Days Ago-0.13-0.1-0.48-0.69
90 Days Ago-0.13-0.1-0.48-0.69
EPS RevisionsCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/A1N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesGALTIndustrySectorS&P 500
Current Qtr.14.30%N/AN/A0.42
Next Qtr.7.70%N/AN/A0.45
Current Year6.10%N/AN/A0.21
Next Year-69.60%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A